MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis

Abstract

Insights

MicroRNA-155 (miR-155) plays a key role in gouty arthritis by increasing inflammatory cytokines and decreasing SHIP-1 levels. This study clarifies miR-155's function in gout pathogenesis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Gout is a painful inflammatory arthritis caused by monosodium urate (MSU) crystals.
  • MicroRNA-155 (miR-155) is known to be important in myeloid cell activation and inflammatory arthritis.
  • The specific role of miR-155 in acute gouty arthritis was previously undefined.

Purpose of the Study:

  • To investigate the role of miR-155 in the pathogenesis of acute gouty arthritis.
  • To determine the relationship between miR-155, SHIP-1, and inflammatory cytokine production in gout.

Main Methods:

  • Collected samples from gout patients and healthy controls.
  • Cultured peripheral blood mononuclear cells (PBMCs) and synovial fluid mononuclear cells (SFMCs) with MSU crystals.
  • Assessed gene expression of miR-155 and SHIP-1 using real-time PCR.
  • Measured inflammatory cytokine levels (TNF-α, IL-1β) via Luminex.
  • Utilized a mouse model of gout to analyze miR-155, SHIP-1, and cytokine expression.

Main Results:

  • miR-155 expression was significantly elevated in gout samples compared to healthy controls.
  • MSU crystal stimulation strongly induced miR-155 expression in vitro.
  • Overexpression of miR-155 led to decreased SHIP-1 levels and increased production of pro-inflammatory cytokines (TNF-α, IL-1β).
  • Elevated miR-155 and inflammatory cytokine production were observed in a mouse model of gout.

Conclusions:

  • miR-155 overexpression in gouty synovial fluid mononuclear cells suppresses SHIP-1 levels.
  • miR-155 enhances the production of pro-inflammatory cytokines, contributing to gout pathogenesis.